DRUG STUDY

CLASSIFICATION
NAME OF ADVERSE NURSING MONITORING
& INDICATIONS CONTRAINDICATION
DRUGS REACTION RESPONSIBILITY PARAMETERS
ACTION

Generic Anti- infectives  Serious UTI CNS: seizures,  Contraindicated  Obtain  May increase
Name: and lower headache, in patients specimen for alkaline
>Ceftazidime > Third- generation respiratory dizziness, hypersensitive culture and phosphatase,
cephalosporin that tract parethesia to drugs or other sensitivity tests ALT, AST,
Brand Name: inhibit cell- wall infection; cephalosporins. before giving bilirubin and
> Ceptaz synthesis. skin; CV: Phelibitis, first dose. LDH levels. May
Promoting osmotic gynecologic thrombophebitis Therapy may decrease
Dosage: instability ; usually , CNS  Use cautiously begin while hemoglobin
>300 ml bactericidal infection. GI: nausea, in patients awaiting results. level.
vomiting, hypersensitive
Route: diarrhea, to penicillin  For I.M. use,  May increase
>Through IV abdominal because of inject deep into eosinophil
cramps possibility of a large muscle, count. May
Frequency:: . cross- sensitivity such as the decrease
>q 8 0 GU: vaginitis with other beta- gluteus granulocyte and
lactam maximus or the WBC counts.
Form: Hematologic: antibiotics side of the
>Solution agranulocytosis, thigh.
leukopemia, ALT =5 – 28 u/L
eosinophilia BUN =8.2 – 20 mg/dL
Creatinine =0.4 – 0.7
SKIN: mg/dL
maculopapular AST =15 – 30 u/L
and erythenayous Bilirubin =0 – 3.4
rahes umol/L
Hgb=12 – 16 g/Dl
OTHER: WBC=4,500 – 11,000
anaphylaxis cubic mm
Eosinophil =0 – 4%
Platelet =150,000 –
4500,000 cubic mm
LDH =60 – 160 mg/dL